Biolife Solutions (BLFS) Asset Writedowns and Impairment (2016 - 2023)
Biolife Solutions (BLFS) reported Asset Writedowns and Impairment of $8.3 million for Q3 2023, up 111.89% on a QoQ basis from -$69.9 million in Q4 2022.
Biolife Solutions (BLFS) has 4 years of Asset Writedowns and Impairment data on file, last reported at $8.3 million in Q3 2023.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $8.3 million in Q3 2023, while the trailing twelve-month figure through Dec 2024 was -$61.6 million (changed N/A YoY) and the FY2023 annual result came in at $9.7 million, changed N/A from the prior year.
- Asset Writedowns and Impairment improved to $8.3 million in Q3 2023 per BLFS's latest filing, from -$69.9 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $69.9 million in Q2 2022 and bottomed at -$69.9 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 8.31 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Dec 31, 2022 | -69.90 Mn |
| Dec 31, 2022 | -69.90 Mn |
| Jun 30, 2022 | 69.90 Mn |
| Jun 30, 2022 | 69.90 Mn |
| Dec 31, 2017 | 336.00 |
| Dec 31, 2017 | 336.00 |
| Sep 30, 2017 | 67,664.00 |
| Sep 30, 2017 | 67,664.00 |
| Jun 30, 2016 | 86,736.00 |
| Jun 30, 2016 | 86,736.00 |